Influenza
News from the FDA/CDC
2016-2017 flu season continues to wind down
Outpatient visits continue to drop nationally, but influenza activity remains high in most southern states.
News from the FDA/CDC
U.S. influenza activity remains steady
The proportion of U.S. outpatient visits for influenza-like illness stayed at 3.7% for a second consecutive week after declining the previous 3...
News from the FDA/CDC
U.S. flu activity continues to decline
The 2016-2017 U.S. influenza season appears to have peaked, as activity measures dropped for the third consecutive week.
News
FDA committee approves strains for 2017-2018 flu shot
ROCKVILLE, MD. – A committee of Food and Drug Administration advisers backed the World Health Organization’s influenza vaccine recommendations for...
News from the FDA/CDC
Outpatient flu visits down slightly
The national proportion of outpatient visits for influenza-like illness decreased from 5.2% the previous week to 4.8% for the week ending Feb. 18...
News from the FDA/CDC
Twenty-five states at highest flu activity level
2016-2017 influenza season shows no signs of slowing down.
News from the FDA/CDC
Flu activity levels high in 23 states
Main nationwide influenza activity measure reaches it highest point since the end of 2014.
News from the FDA/CDC
High levels of flu activity reported in 15 states
Fifteen states experienced high levels of flu activity for the week ending Jan. 28 as the 2016-2017 season moved past last season’s peak,...
News from the FDA/CDC
Increase brings flu activity back to seasonal high
The level of influenza-like illness activity was highest in five states for the week ending Jan. 21, compared with three states the week before,...
News from the FDA/CDC
Flu activity up slightly, but still down from seasonal peak
After rising to a high point for the season in the last week of 2016, influenza activity dropped a bit in the first week of the new year but then...
From the Journals
Double-dose influenza vaccine effective against type B strains
All children under the age of 3 years benefited from double-dose IIV4 vaccination.